[go: up one dir, main page]

WO1996035788A3 - Peptides inhibiteurs de proteases de type kunitz - Google Patents

Peptides inhibiteurs de proteases de type kunitz Download PDF

Info

Publication number
WO1996035788A3
WO1996035788A3 PCT/US1996/006384 US9606384W WO9635788A3 WO 1996035788 A3 WO1996035788 A3 WO 1996035788A3 US 9606384 W US9606384 W US 9606384W WO 9635788 A3 WO9635788 A3 WO 9635788A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogues
kpi
protease inhibitors
type protease
kunitz type
Prior art date
Application number
PCT/US1996/006384
Other languages
English (en)
Other versions
WO1996035788A2 (fr
Inventor
Tyler R White
Deborah Damm
David D Lesikar
Kethleen Mcfadden
Brett L Garrick
Original Assignee
Scios Inc
Tyler R White
Deborah Damm
David D Lesikar
Kethleen Mcfadden
Brett L Garrick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Inc, Tyler R White, Deborah Damm, David D Lesikar, Kethleen Mcfadden, Brett L Garrick filed Critical Scios Inc
Priority to EP96920140A priority Critical patent/EP0827539A2/fr
Priority to AU58540/96A priority patent/AU5854096A/en
Priority to JP8534170A priority patent/JPH11504938A/ja
Publication of WO1996035788A2 publication Critical patent/WO1996035788A2/fr
Publication of WO1996035788A3 publication Critical patent/WO1996035788A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention se rapporte à des analogues du domaine des inhibiteurs de protéases de type Kunitz (KPI) d'une protéine précurseur amyloïde qui se lient et inhibent l'activité des sérine protéases, telles que la kallikréine, la plasmine, et des facteurs de coagulation tels que les facteurs VIIa, IXa, Xa, XIa et XIIa. Des compositions pharmaceutiques contenant les analogues de KPI, ainsi que les procédés d'utilisation de ces compositions, sont utiles pour améliorer et traiter des pathologies cliniques associées à l'activité de la sérine protéase, telles que des pertes de sang liées à des interventions chirurgicales impliquant une circulation extracorporelle. L'invention se rapporte également à des séquences nucléotidiques codant ces analogues et à des systèmes d'expression des peptides selon l'invention.
PCT/US1996/006384 1995-05-08 1996-05-08 Peptides inhibiteurs de proteases de type kunitz WO1996035788A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96920140A EP0827539A2 (fr) 1995-05-08 1996-05-08 Peptides inhibiteurs de proteases de type kunitz
AU58540/96A AU5854096A (en) 1995-05-08 1996-05-08 Kunitz type protease inhibitors
JP8534170A JPH11504938A (ja) 1995-05-08 1996-05-08 クニッツ型プロテアーゼ阻害因子

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43655595A 1995-05-08 1995-05-08
US08/436,555 1995-05-08
US64373196A 1996-05-06 1996-05-06
US08/643,731 1996-05-06

Publications (2)

Publication Number Publication Date
WO1996035788A2 WO1996035788A2 (fr) 1996-11-14
WO1996035788A3 true WO1996035788A3 (fr) 1996-12-12

Family

ID=27031013

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/006384 WO1996035788A2 (fr) 1995-05-08 1996-05-08 Peptides inhibiteurs de proteases de type kunitz

Country Status (6)

Country Link
EP (1) EP0827539A2 (fr)
JP (1) JPH11504938A (fr)
KR (1) KR19990008458A (fr)
AU (1) AU5854096A (fr)
CA (1) CA2220497A1 (fr)
WO (1) WO1996035788A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921314B2 (en) 2008-10-15 2014-12-30 Angiochem, Inc. Conjugates of GLP-1 agonists and uses thereof
US9161988B2 (en) 2009-07-02 2015-10-20 Angiochem Inc. Multimeric peptide conjugates and uses thereof
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
US9221867B2 (en) 2003-01-06 2015-12-29 Angiochem Inc. Method for transporting a compound across the blood-brain barrier
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DE69735996T2 (de) 1996-03-11 2007-02-15 Bayer Corp. Menschlicher bikunin
WO1999061615A1 (fr) * 1998-05-28 1999-12-02 Zymogenetics, Inc. Polypeptide du domaine de kunitz, materiaux et procedes pour le realiser
EP1082431A2 (fr) * 1998-06-03 2001-03-14 Scios Inc. Peptides inhibiteurs de protease
CA2488558C (fr) 2002-06-07 2013-08-20 Dyax Corp. Prevention et reduction de la perte sanguine
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
AU2005327497B2 (en) 2005-02-18 2012-04-12 Angiochem Inc. Aprotinin polypeptides for transporting a compound across the blood-brain barrier
JP5436856B2 (ja) 2005-07-15 2014-03-05 アンジオケム インコーポレーティッド 薬学的複合体における担体としてのアプロチニンポリペプチドの使用
WO2009080054A1 (fr) * 2007-12-21 2009-07-02 Ifxa A/S Inhibiteur de protéases
CN102307904A (zh) 2008-12-05 2012-01-04 安吉奥开米公司 神经降压素或神经降压素类似物的缀合物及其用途
CA2744235A1 (fr) 2009-01-06 2010-07-15 Dyax Corp. Traitement de la mucosite par des inhibiteurs de kallikreine
PL2521568T3 (pl) 2010-01-06 2019-03-29 Dyax Corp. Białka wiążące kalikreinę osocza
EP2661450A4 (fr) 2011-01-06 2014-04-23 Dyax Corp Protéines se liant à la kallikréine plasmatique
CA2881602A1 (fr) 2012-08-14 2014-02-20 Angiochem Inc. Conjugues peptides-dendrimeres et leurs utilisations
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose
WO2017098516A1 (fr) * 2015-12-10 2017-06-15 The National Institute for Biotechnology in the Negev Ltd. Variantes du domaine inhibiteur du précurseur de la bêta-protéine amyloïde
JP7003354B2 (ja) 2015-12-11 2022-03-04 武田薬品工業株式会社 遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途
CN110051830A (zh) * 2019-03-14 2019-07-26 苏州新凝生物医药科技有限公司 一种protease nexin II\KPI蛋白突变体的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393431A1 (fr) * 1989-04-18 1990-10-24 Bayer Ag Homologues de l'inhibiteur de la protéase d'Alzheimer préparés de manière génétique, des souches hôtes et vecteurs d'expression pour leur préparation et leur utilisation comme médicament
WO1993014120A1 (fr) * 1992-01-07 1993-07-22 Novo Nordisk A/S Variant inhibiteur de la protease humaine de type kunitz
WO1993014119A1 (fr) * 1992-01-07 1993-07-22 Novo Nordisk A/S Variants inhibiteurs de type kunitz de la protease humaine
WO1995023860A2 (fr) * 1994-03-04 1995-09-08 Genentech, Inc. PROTEINES INHIBITRICES PROPRES AU DOMAINE DE KÜNITZ DERIVEES DE L'INHIBITEUR DU PRECURSEUR DE LA β-PROTEINE AMYLOIDE DE LA MALADIE D'ALZHEIMER

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039619A1 (fr) * 1995-06-06 1996-12-12 Kla Instruments Corporation Controle optique d'un specimen au moyen des reactions du specimen dans des canaux multiples

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393431A1 (fr) * 1989-04-18 1990-10-24 Bayer Ag Homologues de l'inhibiteur de la protéase d'Alzheimer préparés de manière génétique, des souches hôtes et vecteurs d'expression pour leur préparation et leur utilisation comme médicament
WO1993014120A1 (fr) * 1992-01-07 1993-07-22 Novo Nordisk A/S Variant inhibiteur de la protease humaine de type kunitz
WO1993014119A1 (fr) * 1992-01-07 1993-07-22 Novo Nordisk A/S Variants inhibiteurs de type kunitz de la protease humaine
WO1995023860A2 (fr) * 1994-03-04 1995-09-08 Genentech, Inc. PROTEINES INHIBITRICES PROPRES AU DOMAINE DE KÜNITZ DERIVEES DE L'INHIBITEUR DU PRECURSEUR DE LA β-PROTEINE AMYLOIDE DE LA MALADIE D'ALZHEIMER

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DENNIS M S ET AL: "Kunitz domain inhibitors of tissue factor-factor VIIa: I. Potent inhibitors selected from libraries by phage display.", JOURNAL OF BIOLOGICAL CHEMISTRY 269 (35). 1994. 22129-22136. ISSN: 0021-9258, XP002015893 *
DENNIS M S ET AL: "Kunitz domain inhibitors of tissue factor-factor VIIa: II. Potent and specific inhibitors by competitive phage selection.", JOURNAL OF BIOLOGICAL CHEMISTRY 269 (35). 1994. 22137-22144. ISSN: 0021-9258, XP002015892 *
DENNIS M S ET AL: "Potent and Selective Kunitz Domain Inhibitors of Plasma Kallikrein Designed by Phage Display.", JOURNAL OF BIOLOGICAL CHEMISTRY 270 (43). 1995. 25411-25417. ISSN: 0021-9258, XP002015896 *
HYNES T R ET AL: "X-RAY CRYSTAL STRUCTURE OF THE PROTEASE INHIBITOR DOMAIN OF ALZHEIMER 'S AMYLOID BETA-PROTEIN PRECURSOR.", BIOCHEMISTRY 29 (43). 1990. 10018-10022. CODEN: BICHAW ISSN: 0006-2960, XP002015891 *
J. PERONA ET AL: "Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI", JOURNAL OF MOLECULAR BIOLOGY, vol. 230, 1993, pages 919 - 933, XP000608106 *
KIDO H ET AL: "PROTEASE-SPECIFICITY OF KUNITZ INHIBITOR DOMAIN OF ALZHEIMER 'S DISEASE AMYLOID PROTEIN PRECURSOR.", BIOCHEM BIOPHYS RES COMMUN 167 (2). 1990. 716-721. CODEN: BBRCA9 ISSN: 0006-291X, XP002015895 *
S. SINHA ET AL: "Conversion of the Alzheimer's beta-Amyloid precursor protein (APP) Kunitz domain into a potent human neutrophil elastase inhibitor", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 31, 5 November 1991 (1991-11-05), MD US, pages 21011 - 21013, XP002015894 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9221867B2 (en) 2003-01-06 2015-12-29 Angiochem Inc. Method for transporting a compound across the blood-brain barrier
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8921314B2 (en) 2008-10-15 2014-12-30 Angiochem, Inc. Conjugates of GLP-1 agonists and uses thereof
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
US9161988B2 (en) 2009-07-02 2015-10-20 Angiochem Inc. Multimeric peptide conjugates and uses thereof

Also Published As

Publication number Publication date
WO1996035788A2 (fr) 1996-11-14
AU5854096A (en) 1996-11-29
KR19990008458A (ko) 1999-01-25
EP0827539A2 (fr) 1998-03-11
JPH11504938A (ja) 1999-05-11
CA2220497A1 (fr) 1996-11-14

Similar Documents

Publication Publication Date Title
WO1996035788A3 (fr) Peptides inhibiteurs de proteases de type kunitz
DE59007737D1 (de) Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel.
TR199902692T2 (xx) Serin proteaz inhibit�rleri.
CA2058935A1 (fr) Compositions pharmaceutiques et methode de traitement a l'aide de peptides amyloides d'alzheimer
CA2421548A1 (fr) Inhibiteurs amidine des serines proteases
WO2003066824A3 (fr) Peptides du domaine kunitz fusionnes a l'albumine
ATE307111T1 (de) Serinprotease-inhibitoren
SE0201976D0 (sv) Novel compounds
BR9713328A (pt) Aminoguanidinas e alcoxiguanidinas como inibidores de proteases.
NO983688L (no) Serin-protease-inhibitorer
WO1999063090A3 (fr) Peptides inhibiteurs de protease
AU639257B2 (en) Proteins having anticoagulant properties
Flight et al. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents
WO2004113278A3 (fr) Inhibiteurs d'acylsulfamide de facteur viia
NZ319474A (en) Guanidino protease inhibitors
DK0833848T3 (da) Faktor IX-bindende peptider afledt af faktor VIII og anvendelse heraf som inhibitorer af blodkoagulation
Schoenberger et al. Limited proteolysis of Cl‐inhibitor by chymotrypsin‐like proteinases
Sulikowski et al. α1‐Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1
JP2839825B2 (ja) 新規トリプシン様酵素
Sugawara et al. Human α-and γ-thrombin inhibition by trypsin inhibitors supports predictions from molecular graphics experiments
Schmaier Gene expression, regulation and cell surface presentation of the kininogens
BR0212122A (pt) Arginais de peptìdeo e métodos para tratamento de coagulação intravascular disseminada
Kobayashi et al. Urinary trypsin-inhibitor protects neutrophil chemotaxis in the inflammatory response
KOSAKI et al. Application of a Synthetic Serine Protease Inhibitor in the
Rarabas et al. Investigations of thrombin inhibitors in fibrinolytic systems

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2220497

Country of ref document: CA

Ref country code: CA

Ref document number: 2220497

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1019970707988

Country of ref document: KR

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1996 534170

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996920140

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996920140

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019970707988

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1019970707988

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1996920140

Country of ref document: EP